Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders
Cannabidiol (CBD) is a phytocannabinoid with a broad-range of therapeutic potential in several conditions, including neurological (epilepsy, neurodegenerative diseases, traumatic and ischemic brain injuries) and psychiatric disorders (schizophrenia, addiction, major depressive disorder, and anxiety)...
Saved in:
Main Authors: | Franciele F. Scarante (Author), Melissa A. Ribeiro (Author), Ana F. Almeida-Santos (Author), Francisco S. Guimarães (Author), Alline C. Campos (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
by: Alline C. Campos, et al.
Published: (2017) -
A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders
by: Oluwadara Pelumi Omotayo, et al.
Published: (2024) -
Cannabidiol: main mechanisms of action and therapeutic targets
by: Klaudia Kowalczyk, et al.
Published: (2023) -
Phenols and GABAA receptors: from structure and molecular mechanisms action to neuropsychiatric sequelae
by: Sergey A. Menzikov, et al.
Published: (2024) -
Spontaneous Activity of CB2 Receptors Attenuates Stress-Induced Behavioral and Neuroplastic Deficits in Male Mice
by: Melissa A. Ribeiro, et al.
Published: (2022)